Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 28Small Cell Lung Carcinoma 24Fallopian Tube Neoplasms 12Uterine Cervical Neoplasms 8Carcinoma, Ovarian Epithelial 8Neuroblastoma 7Lung Neoplasms 6Sarcoma 3Neoplasms 3Retinoblastoma 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Ganglioneuroblastoma 2Carcinoma, Non-Small-Cell Lung 2Solid Tumors 1SCLC 1Rhabdomyosarcoma 1Retinal Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Peritoneal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Localized Extraskeletal Ewing Sarcoma 1Leukemia 1Eye Neoplasms 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Endometrial Neoplasms 1Carcinoma 1

Interventions

pertuzumab 1iniparib 1Trastuzumab 1Topotecan 1Palonosetron 1Paclitaxel 1Metoclopramide 1Irinotecan 1Gemcitabine 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Solid Tumors × Topotecan × Clear all
NCT01593228 2017-09-19

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Sanofi

Phase 3 Completed
37 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡